CEACAM5 and Ascites: In stage 4 subgroup, the non-curative surgery plus first-line chemotherapy, no baseline ascites, baseline serum CEA < median, baseline serum carbohydrate antigen 19-9 (CA19-9) < median were independent prognostic factors for prolonged OS (See Table S3).